Tag:
NanoString Technologies
Latest Headlines
Latest Headlines
Ex-Genzyme CEO Termeer, GE back translational tech with $20M round
Henri Termeer may have retired from Genzyme after the Sanofi buyout, but he hasn't lost his appetite for betting on promising new technologies for the life sciences field. This morning Seattle-based
NanoString rings up $30M in Series C
Seattle-based NanoString Technologies is getting a $30 million boost to help it commercialize "user-friendly technology for characterizing and quantifying expression profiles in complex biological
